{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:39:25Z","timestamp":1787161165352,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DST-INSPIRE Fellowship"},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tuberculosis (TB) elimination is possible with the discovery of accurate biomarkers that define the stages of infection. Drug-resistant TB impair the current treatment strategies and worsen the unfavourable outcomes. The knowledge on host immune responses between drug-sensitive and drug-resistant infection is inadequate to understand the pathophysiological differences and disease severity. The secreted proteins, cytokines display versatile behaviour upon infection with\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (MTB) and their imbalances often tend to assist disease pathology than protection. Therefore, studying these soluble proteins across TB infection spectrum (drug-resistant TB, drug-sensitive TB, and latent TB) may unveil the disease mediated responses and unique stage specific cytokine signatures. Thus, we sought to determine the plasma cytokine levels from healthy, latently infected, drug-sensitive, and drug-resistant TB individuals. Our study revealed top 8 cytokines (IL-17, IL-1\u03b1, IL-2, IL-10, IL-5, IFN-\u03b3, TNF-\u03b1 and IL-6) and their biomarker abilities to discriminate different stages of infection.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-27895-8","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:05:15Z","timestamp":1673849115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity"],"prefix":"10.1038","volume":"13","author":[{"given":"Pavithra","family":"Sampath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alangudi Palaniappan","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Hissar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavan","family":"Dhanapal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharathiraja","family":"Thangavelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavanya","family":"Jayabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paranchi Murugesan","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Devi","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramalingam","family":"Bethunaickan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"27895_CR1","unstructured":"World Health Organization. Global tuberculosis report 2021. (World Health Organization, 2021)."},{"key":"27895_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tube.2006.05.004","volume":"87","author":"S Ahmad","year":"2007","unstructured":"Ahmad, S., Jaber, A.-A. & Mokaddas, E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis 87, 123\u2013129 (2007).","journal-title":"Tuberculosis"},{"key":"27895_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1309\/DKKECWQWMG4J23E3","volume":"129","author":"AB Pulimood","year":"2008","unstructured":"Pulimood, A. B., Peter, S., Rook, G. W. A. & Donoghue, H. D. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am. J. Clin. Pathol. 129, 846\u2013851 (2008).","journal-title":"Am. J. Clin. Pathol."},{"key":"27895_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044944","volume":"7","author":"Y Yu","year":"2012","unstructured":"Yu, Y. et al. Different patterns of cytokines and chemokines combined with IFN-\u03b3 production reflect mycobacterium tuberculosis infection and disease. PLoS ONE 7, e44944 (2012).","journal-title":"PLoS ONE"},{"key":"27895_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1348-0421.2011.00307.x","volume":"55","author":"AS Mustafa","year":"2011","unstructured":"Mustafa, A. S., Al-Saidi, F., El-Shamy, A. S. M. & Al-Attiyah, R. Cytokines in response to proteins predicted in genomic regions of difference of Mycobacterium tuberculosis: Cytokines & RD proteins of M. tuberculosis. Microbiol. Immunol. 55, 267\u2013278 (2011).","journal-title":"Microbiol. Immunol."},{"key":"27895_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/00001432-200306000-00004","volume":"16","author":"E-K Jo","year":"2003","unstructured":"Jo, E.-K., Park, J.-K. & Dockrell, H. M. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr. Opin. Infect. Dis. 16, 205\u2013210 (2003).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"27895_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2012.11.005","volume":"66","author":"A Mihret","year":"2013","unstructured":"Mihret, A. et al. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection. J. Infect. 66, 357\u2013365 (2013).","journal-title":"J. Infect."},{"key":"27895_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ofid\/ofz257","volume":"6","author":"NP Kumar","year":"2019","unstructured":"Kumar, N. P., Moideen, K., Banurekha, V. V., Nair, D. & Babu, S. Plasma proinflammatory cytokines are markers of disease severity and bacterial burden in pulmonary tuberculosis. Open Forum Infect. Dis. 6, 257 (2019).","journal-title":"Open Forum Infect. Dis."},{"key":"27895_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641065","volume":"12","author":"S Rambaran","year":"2021","unstructured":"Rambaran, S. et al. Effect of Inflammatory Cytokines\/chemokines on pulmonary tuberculosis culture conversion and disease severity in HIV-infected and -uninfected individuals from South Africa. Front. Immunol. 12, 641065 (2021).","journal-title":"Front. Immunol."},{"key":"27895_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molimm.2014.06.002","volume":"62","author":"IH Chowdhury","year":"2014","unstructured":"Chowdhury, I. H. et al. Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy. Mol. Immunol. 62, 159\u2013168 (2014).","journal-title":"Mol. Immunol."},{"key":"27895_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","volume":"4","author":"R Domingo-Gonzalez","year":"2016","unstructured":"Domingo-Gonzalez, R., Prince, O., Cooper, A. & Khader, S. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol. Spectr. 4, 1. https:\/\/doi.org\/10.1128\/microbiolspec.TBTB2-0018-2016 (2016).","journal-title":"Microbiol. Spectr."},{"key":"27895_CR12","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3390\/ijms23031112","volume":"23","author":"M Druszczy\u0144ska","year":"2022","unstructured":"Druszczy\u0144ska, M., Godkowicz, M., Kulesza, J., Wawrocki, S. & Fol, M. Cytokine receptors-regulators of antimycobacterial immune response. Int. J. Mol. Sci. 23, 1112 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"27895_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1600-065X.2008.00702.x","volume":"226","author":"AM Cooper","year":"2008","unstructured":"Cooper, A. M. & Khader, S. A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226, 191\u2013204 (2008).","journal-title":"Immunol. Rev."},{"key":"27895_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fvl.12.123","volume":"8","author":"NF Walker","year":"2013","unstructured":"Walker, N. F., Meintjes, G. & Wilkinson, R. J. HIV-1 and the immune response to TB. Future Virol. 8, 57\u201380 (2013).","journal-title":"Future Virol."},{"key":"27895_CR15","doi-asserted-by":"crossref","unstructured":"Tania Beatriz Romero-Adrian, J. L.-M. & Ndez, A. V. Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection. World J. Immunol. 5, 16\u201350 (2015).","DOI":"10.5411\/wji.v5.i1.16"},{"key":"27895_CR16","doi-asserted-by":"crossref","unstructured":"Olsen, A. et al. Targeting mycobacterium tuberculosis tumor necrosis factor alpha-downregulating genes for the development of antituberculous vaccines. mBio 7, e01023-15 (2016).","DOI":"10.1128\/mBio.01023-15"},{"key":"27895_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004603","volume":"11","author":"HP Gideon","year":"2015","unstructured":"Gideon, H. P. et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLOS Pathog. 11, e1004603 (2015).","journal-title":"PLOS Pathog."},{"key":"27895_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.it.2010.12.001","volume":"32","author":"E Torrado","year":"2011","unstructured":"Torrado, E., Robinson, R. T. & Cooper, A. M. Cellular response to mycobacteria: Balancing protection and pathology. Trends Immunol. 32, 66\u201372 (2011).","journal-title":"Trends Immunol."},{"key":"27895_CR19","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3389\/fmicb.2018.02603","volume":"9","author":"C Stek","year":"2018","unstructured":"Stek, C. et al. The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy. Front. Microbiol. 9, 2603 (2018).","journal-title":"Front. Microbiol."},{"key":"27895_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/imr.12671","volume":"285","author":"JM Cicchese","year":"2018","unstructured":"Cicchese, J. M. et al. Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology. Immunol. Rev. 285, 147\u2013167 (2018).","journal-title":"Immunol. Rev."},{"key":"27895_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.2174\/157489108786242332","volume":"3","author":"O Rivero-Lezcano","year":"2008","unstructured":"Rivero-Lezcano, O. Cytokines as immunomodulators in tuberculosis therapy. Recent Patents Anti-Infect. Drug Disc. 3, 168\u2013176 (2008).","journal-title":"Recent Patents Anti-Infect. Drug Disc."},{"key":"27895_CR22","first-page":"88","volume":"107","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. Multiplex analysis of plasma cytokines\/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants. Tuberc. Edinb. Scotl. 107, 88\u201394 (2017).","journal-title":"Tuberc. Edinb. Scotl."},{"key":"27895_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","volume":"174","author":"L Richeldi","year":"2006","unstructured":"Richeldi, L. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174, 736\u2013742 (2006).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"27895_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.drudis.2009.10.005","volume":"15","author":"SK Parida","year":"2010","unstructured":"Parida, S. K. & Kaufmann, S. H. E. The quest for biomarkers in tuberculosis. Drug Discov. Today 15, 148\u2013157 (2010).","journal-title":"Drug Discov. Today"},{"key":"27895_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/immuno1040028","volume":"1","author":"GI Mensah","year":"2021","unstructured":"Mensah, G. I. et al. Identification of serum cytokine biomarkers associated with multidrug resistant tuberculosis (MDR-TB). Immuno 1, 400\u2013409 (2021).","journal-title":"Immuno"},{"key":"27895_CR26","first-page":"E2","volume":"7","author":"A Basingnaa","year":"2018","unstructured":"Basingnaa, A., Antwi-Baffour, S., Nkansah, D. O., Afutu, E. & Owusu, E. Plasma levels of cytokines (IL-10, IFN-\u03b3 and TNF-\u03b1) in multidrug resistant tuberculosis and drug responsive tuberculosis patients in Ghana. Dis. Basel Switz. 7, E2 (2018).","journal-title":"Dis. Basel Switz."},{"key":"27895_CR27","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1155\/MI.2005.256","volume":"2005","author":"F Deveci","year":"2005","unstructured":"Deveci, F., Akbulut, H. H., Turgut, T. & Muz, M. H. Changes in serum cytokine levels in active tuberculosis with treatment. Mediat. Inflamm. 2005, 256\u2013262 (2005).","journal-title":"Mediat. Inflamm."},{"key":"27895_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.841741","volume":"12","author":"NO Amiano","year":"2022","unstructured":"Amiano, N. O. et al. circulating monocyte-like myeloid derived suppressor cells and CD16 positive monocytes correlate with immunological responsiveness of tuberculosis patients. Front. Cell. Infect. Microbiol. 12, 841741 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"27895_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mi.2011.13","volume":"4","author":"AM Cooper","year":"2011","unstructured":"Cooper, A. M., Mayer-Barber, K. D. & Sher, A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 4, 252\u2013260 (2011).","journal-title":"Mucosal Immunol."},{"key":"27895_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humimm.2013.09.009","volume":"75","author":"JAS Gomes","year":"2014","unstructured":"Gomes, J. A. S. et al. Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease. Hum. Immunol. 75, 20\u201328 (2014).","journal-title":"Hum. Immunol."},{"key":"27895_CR31","first-page":"76","volume":"27","author":"NA T\u00e9llez-Navarrete","year":"2021","unstructured":"T\u00e9llez-Navarrete, N. A. et al. Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: However, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time. Mol. Med. Camb. Mass 27, 76 (2021).","journal-title":"Mol. Med. Camb. Mass"},{"key":"27895_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","volume":"27","author":"AM Cooper","year":"2009","unstructured":"Cooper, A. M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393\u2013422 (2009).","journal-title":"Annu. Rev. Immunol."},{"issue":"176","key":"27895_CR33","first-page":"4804","volume":"1950","author":"S T\u00f6temeyer","year":"2006","unstructured":"T\u00f6temeyer, S. et al. IFN-gamma enhances production of nitric oxide from macrophages via a mechanism that depends on nucleotide oligomerization domain-2. J. Immunol. Baltim. Md 1950(176), 4804\u20134810 (2006).","journal-title":"J. Immunol. Baltim. Md"},{"key":"27895_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/intimm\/dxq429","volume":"22","author":"AMM Mattos","year":"2010","unstructured":"Mattos, A. M. M. et al. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int. Immunol. 22, 775\u2013782 (2010).","journal-title":"Int. Immunol."},{"key":"27895_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clim.2010.09.005","volume":"138","author":"J Nemeth","year":"2011","unstructured":"Nemeth, J. et al. Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin. Immunol. Orlando Fla 138, 50\u201359 (2011).","journal-title":"Clin. Immunol. Orlando Fla"},{"key":"27895_CR36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1365-2567.1997.00193.x","volume":"90","author":"R Hernandez-Pando","year":"1997","unstructured":"Hernandez-Pando, R. et al. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 90, 607\u2013617 (1997).","journal-title":"Immunology"},{"key":"27895_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/cmi.2018.5","volume":"16","author":"K Harling","year":"2019","unstructured":"Harling, K. et al. Constitutive STAT3 phosphorylation and IL-6\/IL-10 co-expression are associated with impaired T-cell function in tuberculosis patients. Cell. Mol. Immunol. 16, 275\u2013287 (2019).","journal-title":"Cell. Mol. Immunol."},{"key":"27895_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ebiom.2017.10.018","volume":"25","author":"GB Sigal","year":"2017","unstructured":"Sigal, G. B. et al. Biomarkers of tuberculosis severity and treatment effect: A directed screen of 70 host markers in a randomized clinical trial. EBioMedicine 25, 112\u2013121 (2017).","journal-title":"EBioMedicine"},{"key":"27895_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015619","volume":"5","author":"R Casey","year":"2010","unstructured":"Casey, R. et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS ONE 5, e15619 (2010).","journal-title":"PLoS ONE"},{"key":"27895_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm.2299","volume":"17","author":"A Harari","year":"2011","unstructured":"Harari, A. et al. Dominant TNF-\u03b1+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 17, 372\u2013376 (2011).","journal-title":"Nat. Med."},{"key":"27895_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012365","volume":"5","author":"JS Sutherland","year":"2010","unstructured":"Sutherland, J. S., de Jong, B. C., Jeffries, D. J., Adetifa, I. M. & Ota, M. O. C. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 5, e12365 (2010).","journal-title":"PLoS ONE"},{"key":"27895_CR42","doi-asserted-by":"publisher","first-page":"2100905","DOI":"10.1183\/13993003.00905-2021","volume":"59","author":"AN Gupte","year":"2022","unstructured":"Gupte, A. N. et al. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: A multisite discovery and validation study. Eur. Respir. J. 59, 2100905 (2022).","journal-title":"Eur. Respir. J."},{"key":"27895_CR43","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cyto.2010.07.001","volume":"52","author":"VH Sai Priya","year":"2010","unstructured":"Sai Priya, V. H., Latha, G. S., Hasnain, S. E., Murthy, K. J. R. & Valluri, V. L. Enhanced T cell responsiveness to Mycobacterium bovis BCG r32-kDa Ag correlates with successful anti-tuberculosis treatment in humans. Cytokine 52, 190\u2013193 (2010).","journal-title":"Cytokine"},{"key":"27895_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.892701","volume":"13","author":"P Sampath","year":"2022","unstructured":"Sampath, P. et al. Differential frequencies of intermediate monocyte subsets among individuals infected with drug-sensitive or drug-resistant mycobacterium tuberculosis. Front. Immunol. 13, 1 (2022).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27895-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27895-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T06:12:09Z","timestamp":1673849529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27895-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27895"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-27895-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"785"}}